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Abstract
Nanotechnology has become a research hotspot to explore functional nanodevices and 
design materials compatible with nanoscale topography. Recently, titanium dioxide 
nanotube arrays (TNA) have garnered considerable interest as biomedical implant mate-
rials and nanomedicine applications (such as nanotherapeutics, nanodiagnostics and 
nanobiosensors). In bio-implants studies, the properties of TNA nanostructures could 
modulate diverse cellular processes, such as cell adhesion, migration, proliferation, 
and differentiation. Furthermore, this unique structure of TNA provides larger surface 
area and energy to regulate positive cellular interactions toward the mechanosensitivity 
activities. As for an advanced medical application, the TNA—biomolecular interactions 
knowledge are critical for further characterization of nanomaterial particularly in nano-
therapeutic manipulation. Knowledge of these aspects will create opportunities for better 
understanding which may help researchers to develop better nanomaterial products to 
be used in medicine and health-line services.
Keywords: titanium dioxide nanotube arrays, titania, titanium dioxides nanomaterial, 
biomaterial, nanomedicine, nanotherapeutic manipulation
1. Nano-properties of titanium dioxide nanotube arrays
Titanium dioxide (TiO
2
) nanotube arrays are also referred to as titania nanotube arrays (TNA). 
Nanotubes layered by anodization in particular, have garnered considerable interest in the 
enhancement of orthopedic procedures due to their inherent high quality and cost-effectiveness 
[1, 2]. The anodization process produces continuous and vertically aligned TiO
2
 nanotubes 
structure in an array form on the titanium (Ti) alloy surface as shown in Figure 1.
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Several researchers have investigated a range of parameters associated with the physical and ele-
ment properties of TNA. The physical parameters involve different crystal structures, nanotubes 
diameter and length, as well as surface roughness. The element contents are the core composi-
tions of TNA. The effect of different parameters could solely or communally modulate diverse 
cellular responses of the cells adhesion, migration, proliferation and differentiation [3, 4].
Interaction of these parameters may also result in the wettability factors of cellular interaction 
and biocompatibility [5]. Hence, these parameters need to be optimized before performing a 
detailed study of the material. This might also help in gaining an understanding of the cell-
nanostructure interactions and designing novel regenerative biomaterials that could favor-
ably modulate cellular responses to enhance the tissue regeneration [6–8].
The Ti surface readily reacts with oxygen upon contact and results in three titanium oxide crys-
talline phases such as rutile, brookite and anatase. These phases may also be responsible for 
the material biological properties [9]. Anatase phase is metastable and exhibit stronger inter-
actions between metal and support, which would be advantageous for medical application 
[10]. Anatase phase shows better absorption properties of hydroxyl-OH- and phosphate-PO
4
3+ 
than rutile titania in simulated body fluid which could favor bonelike apatite component to be 
Figure 1. TNA nanomatrix observation by field emission scanning electron microscopy. (A) The surface modification 
by anodization produced nanotubular structure of TiO
2
 layer (TNA) in vertical view and (B) nanoporous structure from 
top view; the formation of well-aligned nanotubular structure (nanotubes). The nanotubes were linked to each other and 
ripple marks occurred at the sidewalls.
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deposited [9]. The deposition of bone-like apatite component is crucial in mediating a positive 
osseointegration, the interaction of implant surface with surrounding bone tissues [11, 12].
Therefore, anatase crystal phase TNA has become a major interest in medical research. A 
study by Yu et al. [13] reported that anatase TNA could yield an optimal biological response 
for cell adhesion, spreading, proliferation and differentiation. TNA with 100 nm diameter 
have been suggested to provide similar characteristic as the natural bone topography com-
prising nanophase hydroxyapatite (100 nm size regime) in the collagen matrix [14, 15].
2. Potential application of TNA in biomedical implants
Biomaterials are the core needs in diverse medical areas such as for the orthopedic, dental, 
cardiovascular, and craniofacial implants [59–64]. In the past, Ti or Ti alloys were commonly 
used as biomaterial implants [16]. Besides having great mechanical properties and excellent 
corrosion resistance, titanium possesses a good biocompatibility, which related to the behav-
ior and function of nontoxic materials in living systems [17, 18].
This metal surface is known to be cytocompatible, which refers to the ability to bind with bio-
molecules and supported cellular attachment (adhesion), growth and proliferation [11, 19–22]. 
Conventionally, Ti alloys have a thin layer of titania also known as titanium oxide (TiO
2
) on the 
surface. This naturally occurring oxide of titanium (Ti4+) resulted from the reduction–oxidation 
action of surrounding oxygen (O
2
4−) and water (H
2
O) [23]. This oxidized layer of Ti is known 
to be bioactive which makes it possible to establish direct contact with bone cells and promote 
the formation of apatite (major component of bone tissue) [24].
To meet the expectation of successful biomedical implants, there is a critical need in reduc-
ing the post-operation healing time and safe placement of implants have become a major con-
cern. This is because the human body has minimum time to react to osseointegration before the 
body starts rejecting the implants. The currently available implants possess these limitations. 
For instance, at the early stage of implantation of Ti implant materials into human body, the 
material surface cannot bind directly to living bone due to biologically inert metallic surface 
properties [25]. Hence, the healing period takes a longer time and sometimes the surface gets 
encapsulated over the time [26]. This attributes to poor osseointegration, leading to aseptic loos-
ening of the implant, development of fibrous tissue (at interface of implant-bone), micromotion 
(at interface of bone implant) and/or wear debris formation (wear particles of bone implant 
interface) and further delamination (or fracture) between bone and implant material [26, 27].
The surface of implant materials plays a vital role in controlling osseointegration to decrease 
healing time; in this regard, scholars aim to improve or alter the biocompatibility of Ti implant 
surface for long-term clinical use [16]. Current studies focus on the potential of titania with a 
three-dimensional (3-D) microporous or nanoporous structure to enhance the formability of 
apatite (bone component) and the adherence speed of osteoblastic cells compared with that 
of a dense titania layer [28–30]. The nanometric scaled surface modification has shown to be 
critical for the tissue acceptance and cell survival.
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Notably, the proposed TNA structure has adaptive features which are required to successfully 
improve cell interaction with the implant materials. The continuous and vertically aligned TNA 
topography demonstrates extremely larger surface area than the flat titanium surface and has 
been assumed to overcome current clinical implants limitations [31]. Moreover, this improved 
bioactive layer of inward growth TiO
2
 nanotubes on Ti provides good adherence of the nano-
tube layer to the titanium metal which eventually rectifies the problems of existing ceramic 
coatings arising from weak interfacial bonding [28]. Besides that, TNA topography may pro-
vide similar characteristic as a natural bone topography (pore size/diameter ~ 60–100 nm) that 
might improve the interference of bone cells response [15].
Furthermore, the unique structure of TNA exhibit surface area that is three times higher 
than that of flat titanium, creating additional spaces for cell interaction particularly at the cell 
extracellular matrix level; this structure may also address the limitations of existing clinical 
implants [14, 21, 32, 33]. Moreover, the improved bioactive layer of the oxide nanotube struc-
tures on Ti allows the nanotube layer to adhere to the titanium metal (metastable), leading 
to stronger interfacial bonding that that of existing ceramic coatings [34]. These nanostruc-
ture properties can increase the surface energy and improve interactions with various pro-
teins (such as vitronectin and fibronectin), resulting in enhanced specific cell adhesion and 
osseointegration [13, 35–38]. Yu et al. [13] reported that anatase TNA elicits optimal biological 
responses for cell adhesion, spreading, proliferation, and differentiation. Furthermore, the 
surfaces of these nanostructures can effectively reduce inflammatory responses compared 
with surfaces of conventional implants [39–41]. Therefore, the proposed TNA structure pos-
sesses adaptive features that can successfully improve cell interaction with the implant mate-
rials and may potentially enhance osseointegration [42–44].
2.1. Examples of biomedical implants
An orthopedic implant is a medical device built from metallic alloys such as Ti which is used 
to replace a missing joint or bone or to support a damaged bone. It may consist of a single type 
or comprise modular parts of biomaterial. For example, bone plates and bone screws used 
in spinal fusion surgery and fixation of fractured bone part. Meanwhile, the hip and knee 
replacements are medically termed as artificial joints or prostheses used to treat various type 
of arthritis affecting these joints, which are common health complaints in elderly patients. 
Besides, the bone implants are also used to treat the bone damaged from accident or cancer or 
musculoskeletal diseases [30].
Dental implant is an artificial tooth root made of Ti used to place into the jaw and hold a 
dental prosthesis as replacement for tooth or bridge. This technique was invented in 1952 by a 
Swedish orthopedic surgeon named Per-Ingvar Brånemark [45]. The implant is considered the 
standard in replacement of missing teeth due to periodontal diseases, injuries, or some other 
reasons [46]. Dental implants are divided into three types, namely, the osseointegrated, mini-
implant for orthodontic anchorage, and zygomatic [47]. Besides, another important implant 
used in dental application is the titanium mesh membrane. This barrier implant membrane 
surface provides great mechanical properties for Guided Bone Regeneration (GBR) treatment 
to assist the new bone formation [48].
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Cardiovascular implants use Ti metals for the replacement of heart valves (pacemaker cases 
and defibrillators), endovascular stents, and stent-graft combinations. These implants help to 
overcome cardiovascular diseases which physically damage the heart, resulting in loss of car-
diac function. The types of implants are classified as temporary internal, temporary external 
and permanent internal devices. One of the demands is stents which include the bare metal 
stents, drug-eluting stent, and bioabsorbable stents [49]. Craniofacial implants are important 
in the application of craniofacial prostheses or also known as an epistheses. Epistheses may 
be used to repair or improve absence of facial structures due to malformation present at birth, 
operations that involve treatment for cancer, or trauma. The osseointegrated titanium implant 
is one of the common types of implants used in epistheses [45].
Further development and improvement on the implant is required for complete compatibility 
with the area of implantation, for shorter surgical duration and improved cosmesis [30, 50].
3. Potential application of TNA in nanomedicine
The application of nanotechnology in medicine has led to a new concept termed as nano-
medicine. Nanosized materials exhibit extraordinary functional characteristics due to their 
unique dimension properties. This nanomaterial technology could lead to advances in medi-
cal therapies various diseases, especially cancers. TNA might improve efficiency of an exist-
ing therapies and diagnostic methods. In addition, this it could also reduce the total medical 
care expenses. The further prospect of TNA will be discussed in this section especially for 
nanotherapeutics, nanodiagnostics, and nanobiosensors applications [42].
3.1. Nanotherapeutics: Nanomedicine in therapy
3.1.1. Nanodrug delivery agents
New nanoengineering approaches allow target drug delivery, improve drug solubility, increase 
therapeutic index, extend drug half-life, and decrease drug immunogenicity. Nanotherapeutics 
enables the delivery of drugs to specific cells by using nanostructured materials [51]. This prop-
erty overcomes the limitations of systemic drug administration and may potentially revolu-
tionize treatment of numerous diseases [52].
3.1.2. Nanomatrix therapeutic induction
The inner volume of TiO
2
 nanotubes can be also filled with chemicals and biomolecules, 
such as enzymes or proteins. Subsequently, TNA could be applied into new drug-releasing 
implants for emerging therapies for localized drug delivery [53, 54]. Whereby, the TNA 
topology can be coated with inflammation-reducing drugs, such as dexamethasone, by using 
simple physical adsorption or deposition of the drug by magnetic stimuli-responsive drug 
delivery system as described in Figure 2. This technology may act together radiation therapy 
and even stem cell transplant for an intensification therapy which also known as consolida-
tion or postremission therapy.
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3.1.3. Nano-immunomodulatory agents
Nanomaterial technology allows the development of new immunomodulatory agents, which 
are either immunologically active components or immunosuppressive agents. This nano-
structured material could effectively surpass vaccination, adjuvants, and other immunomod-
ulatory drug treatments. Besides, this unique surface structure could act together with an 
immunosuppressive agent to therapeutically prevent damage to immune response toward 
unsuccessful transplant in allergic or even localized autoimmune reaction. Hence, this tech-
nology could improve the clinical outcomes of treatments for a range of infectious and non-
infectious diseases [55].
Figure 2. TNA nanomatrix as therapeutics system. (A) The system composes TNA structures created on a Ti surface, 
(B) loaded with drug-encapsulated polymer micelles at the top acting as drug-carriers and magnet nanoparticles (MNs) 
at the bottom of the nanotubes. A magnetic stimulated release of drug-carriers was achieved by activating magnetic 
nanoparticles loaded at the bottom of the nanotubes. (C) The drug may move from a region of high concentration to one 
of lower concentration via passive diffusion activity. (D) The stimuli-release concept is based on applying a magnetic 
field to induce the movement of magnetic particles from the bottom and force the release polymer micelles out from the 
TNA.
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3.1.4. Nano-antibacterial agents
Bacterial infection of in-dwelling medical devices could be controlled by the technology of 
TNA nanomatrix surface coated with infection-reducing drugs, such as penicillin and strep-
tomycin (Figure 3). Traditional antibiotic treatment is limited in solving the bacterial infection 
problem. Kulkarni et al. [58] discovered that the use of nanotubes with large diameter (30–
100 nm) might reduce the growth of bacteria, such as Staphylococcus aureus and Staphylococcus 
epidermidis, compared with the smaller size of nanotube (20 nm).
3.1.5. Nano-blood-contacting agents
Adsorption of blood proteins is the immediate primary outcome observed at the implant–
liquid interface [55]. TNA able to increase the formation of fibrin network by transforming 
Figure 3. TNA as nano-antibacterial agent. (A) The TNA could be aligned on any medical device surface (substrate) 
and may act as antimicrobial chemotherapy agent. (B) The bactericidal antibiotics such as Penicillin and Streptomycin can 
be coated at TNA cylindrical inner surface. (C) This antibacterial surface will inhibit and avoid bacteria grow, thus may 
reduce the bacteria infection risk from the system.
Titanium Dioxide Nanotube Arrays for Biomedical Implant Materials and Nanomedicine…
http://dx.doi.org/10.5772/intechopen.73060
475
fibrinogen to fibrin and reduce clotting time also forming dense fibrin network (Figure 4). 
Moreover, TNA elicited low monocyte activation and cytokine secretion. The adsorption of 
biomaterial and blood able to evaluate by using a micro-BCA assay and X-ray photoelectron 
spectroscopy (XPS) [56].
3.2. Nanodiagnostics
Nanobiotechnology and molecular diagnosis are emerging concepts in nanodiagnostics for 
development of personalized medicine or cancer therapy. With the advances in nanotech-
nology, biomarkers can be refined using nanomaterials, which provide high volume/surface 
ratio and multifunctionality. Diagnostic information is obtained based on pharmacogenetics, 
pharmacogenomics, pharmacoproteomics, and environmental factors influencing responses 
to therapy. This approach provides effective and progressive personalized treatment, which 
is tailored directly from the genetic makeup of an individual, thereby preventing unwanted 
side-effects [57].
3.3. Nano-biosensors
Biosensors are analytical devices used to detect biological analytes, such as biomolecules 
(protein, lipid, DNA, and RNA), and biological cells (blood cell, virus, and microorganism). 
These devices present wide applications, including for detection of infectious organisms and 
Figure 4. TNA as nano-blood-contacting agent. The TNA topology could enhance increase the protein adsorption of 
blood serum, adhesion and activation of platelets (fibrin and fibrinogen) and kinetics of whole blood coagulation. Thus, 
the TNA surface may provide interconnecting between the biological substances for providential blood-related implants.
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molecular detection of biomarkers for disease diagnosis. Biosensors consist of physicochemi-
cal transducers (electrochemical, mass, optical, and thermal) and biological analytes as a 
molecular recognition system. The sensitivity of biosensors depends on the properties of the 
transducers and the bio-recognition element. Nanostructured transducers with TNA could 
be used as diagnostic tools with increased sensitivity, specificity, and reliability for medical 
applications [42].
4. Molecular cross-talks between TNA and molecular stability
The nanometric scaled topography of biomedical products plays a decisive role in the sur-
rounding tissue acceptance, cellular stability and cell survival [59–64]. It is important to 
understand nanomaterials-molecular interactions at different cellular mechanisms in order 
to predict the safety of nanomaterials application and their long-term effects. The study of 
molecular signaling pathways could help to explain the cell fate activity when it interacts with 
this nanomaterial. A study by Arcelli et al. [9] has found that Ti with various surface textures 
on osteoblast cells is able to regulate the expression of genes that are linked to osteoblast 
differentiation and bone regeneration such as TIMP1, PTN, and RUNX1 whether directly or 
indirectly. The indirect mechanism has been found through cell communication (PLCG2 and 
EPHA7), cellular proliferation, differentiation (MSX1), cycle regulation (RASSF2 and WDR26) 
and cell adhesion (TNC, TNXB, ZFHX1B and TRPM7).
Furthermore, material surface textures interaction may trigger various cellular mechanisms 
such as tissue remodeling (reorganization or restoration of existing tissues), organization of 
extracellular matrix and protein development, arrangement and disassembly activities (biogen-
esis), bone remodeling (bone matrix, reabsorption minerals and bone development), morpho-
genesis of anatomical structure and macromolecule complex assembly of biological process. 
Most of material surface textures such as nanorough/nanomaterials interactions are predicted 
from functional analysis using bioinformatics software such as gene ontology (GO) analysis 
[64]. However, precise laboratory work needs to be done in accordance with these mechanisms 
and the knowledge of designing safe nano-biomedical products from molecular genetic aspects.
The nanomaterial technology could lead to advances in medical therapies for a variety of 
diseases, especially cancer. Indeed, nanotechnology may have a great impact in medicine and 
healthline. However, little is known about the impact of nanotechnology on human health 
and also on the environment especially in terms of new mechanisms associated with nano-
toxicology [4, 65]. Nanomaterial toxicological profile requires the analysis of different end-
points and cellular mechanisms. Numerous studies have indicated that some nanoparticles 
reveal traces of toxicity in biological systems [66]. This has led to an interest in the area of 
nanotoxicology, which examines the possible toxicity of nanomaterial products for advanced 
medical applications. These research issues have underlined the need for toxicogenomic stud-
ies which govern the examination of toxicology, genomics, proteomics and metabolomics of 
human cells interaction with targeted nanomaterial product. The need of molecular biology 
study on nanomaterial product is important in the development of specific strategies treat-
ment especially in nanotherapeutic manipulation.
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5. Conclusion
Nanotechnology in biomedical field focuses on improving the existing therapies and diag-
nostic methods. The aim of developments in this area is to improve the available practice 
efficiency and reusability, thus saving the total medical cost. Presently, TNA nanostructure 
provides a promising approach for the advanced biomedical implant and nanomedicine 
applications. Furthermore, TNA opens up the possible tie-up in nanotherapeutics, nanodi-
agnostics and nano-biosensors. Further research must be conducted to explore nanomaterial-
biomolecular interactions in order to develop novel or improved biomaterials products for 
medicine and health-line services.
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